Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
September-October 2010 Volume 1 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-October 2010 Volume 1 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Incidental events of diaphragmatic surgery in 82 patients with advanced ovarian, primary peritoneal and fallopian tubal cancer

  • Authors:
    • Fumitoshi Terauchi
    • Aikou Okamoto
    • Yumiko Wada
    • Ei Hasegawa
    • Toru Sasaki
    • Osamu Akutagawa
    • Yasukazu Sagawa
    • Hirotaka Nishi
    • Keiichi Isaka
  • View Affiliations / Copyright

    Affiliations: Department of Obstetrics and Gynecology, Tokyo Medical University, Shinjuku-ku, Tokyo 160-0023, Japan. teralfa@tokyo-med.ac.jp
  • Pages: 861-864
    |
    Published online on: September 1, 2010
       https://doi.org/10.3892/ol_00000152
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Surgical resections, such as peritoneal stripping (peritonectomy) are performed for disseminated diaphragmatic lesions of advanced ovarian cancer. This study retrospectively investigated the incidental events of diaphragmatic surgery. The records of patients with advanced mullerian carcinomas, including ovarian, primary peritoneal and fallopian carcinomas, who underwent diaphragmatic surgery were reviewed. Based on our criteria, stripping was performed for surface disease on the diaphragm, and full-thickness resection was performed for bulky disease. In certain cases, both procedures were performed. We analyzed intra- and post-operative incidental events in 82 patients. The χ2 and Fisher's exact tests were used in the statistical analysis. There were 82 stage III-IV cases of which 56 patients underwent stripping, 12 underwent full-thickness resection and 14 patients underwent both procedures. Unexpected open chest surgery following stripping occurred in 1 out of 63 patients (1.6%) in the primary, 4 out of 13 patients (30.8%) in the interval and 0 out of 6 patients (0.0%) in the secondary debulking surgery groups. The incidence of unexpected open chest surgery was high in the interval debulking surgery group (p<0.001). Regarding post-operative events, accumulation of pleural effusion was identified in 43 patients (52.4%). The incidence of pleural effusions was not significantly different between the two procedures. No complications were encountered, nor was a chest tube required, during unexpected open chest surgery and postoperative pleural effusions. Therefore, it was concluded that special attention should be paid during interval debulking surgery even though it was possible for surgical resections of diaphragmatic lesions to be performed safely.

Introduction

Hoskins et al (1) reported the relationship between the diameter of residual tumors and prognosis in primary debulking surgery (PDS) in ovarian cancer. Subsequently, the importance of PDS has been examined. Although platinum preparations are usually employed, it has been concluded that tumor reduction surgery is a strong determinant factor influencing survival periods in stage III/IV patients. This conclusion was reached following a meta-analysis conducted by Bristow et al (2). The study by these authors is the only available evidence of the effectiveness of surgical therapy with respect to advanced ovarian cancer. In particular, surgical therapy was considered to be optimal when residual tumors were less than 1 cm since the prognosis following surgery was significantly more satisfactory, making PDS the main objective.

Patients with advanced ovarian cancer often have metastatic disease in the upper abdominal region. Nevertheless, it is difficult to achieve optimal surgery using only standard surgical techniques such as hysterectomy, oophorectomy and omentectomy, without a surgical approach that involves upper abdominal surgery (3). Using upper abdominal surgery, the prognosis after optimal surgery is significantly more satisfactory compared to suboptimal cases (3,4,5). In particular, metastases to the diaphragm are common in the latter patients (6). Thus, diaphragmatic surgery is an operational procedure essential in achieving optimal debulking surgery in advanced mullerian carcinomas such as ovarian, primary peritoneal and fallopian tube carcinomas. There are two significant procedures for diaphragmatic surgery: one involves the stripping of disseminated lesions, and the other involves full-thickness resections of nodal lesions which penetrate the diaphragm. The two procedures are often performed simultaneously. Neither of these procedures is frequently performed by gynecological oncologists. In current medical practice, it appears that practitioners lacking experience in such procedures hesitate to perform them due to the possibility of incidental events. This study investigated incidental events retrospectively to evaluate the safety of the two procedures.

Patients and methods

Patients

The medical records of patients with stage III–IV advanced ovarian, primary peritoneal or fallopian carcinomas were reviewed. The patients underwent diaphragmatic surgery at our institution between November 2006 and March 2009, and had preoperative and postoperative chest X-rays to detect and follow pleural effusions.

Methods

In order to obtain adequate exposure and perform diaphragmatic surgery, the infrahepatic edge of the falciform ligament containing the ligamentum teres was divided and ligated. The suture on the upper edge was left long to aid with the downward traction of the liver and remaining falciform ligament. Once the ligamentum teres was divided, the membranous portion of the falciform ligament was divided with the cautery, allowing for the liver to be separated from the anterior abdominal wall. The falciform ligament divides laterally becoming continuous with the anterior right and left coronary ligaments. The distal right hepatic vein and inferior vena cava are found beneath the dissection of the anterior right coronary ligament. For stripping, the whole area of the diaphragm (peritoneum) which contained the discoid lesions was detached or resected. On the other hand, full-thickness resections were performed only when there were obvious nodal masses penetrating the diaphragm by pre-operational imaging studies, or in cases when detachment of the peritoneum became difficult during stripping and when infiltration of deeper muscular layers was suspected. Absorbable sutures (polydioxanone: PDSII®) were used to reconstruct the diaphragm following full-thickness resection. The chest was closed with adequate vacuuming using a suction tube which was removed immediately prior to closing the chest. In principle, thoracic drainage tubes were not put in place.

Statistical analysis

The χ2 and Fisher's exact tests were used for the statistical analysis in this study.

Results

A total of 82 patients who underwent surgery at the Tokyo Medical University Hospital between 2006 and 2009 were analyzed in this study. As noted in Table I, the primary sites were the ovaries in 71 patients, the peritoneum in 9 and the fallopian tubes in 2 patients. The histological types were serous adenocarcinomas including serous papillary in 72 patients, endometrioid adenocarcinomas in 5, mucinous adenocarcinoma in 1 patient and clear cell carcinomas in 4 patients. The majority of cases were serous types.

Table I

Patient characteristics.

Table I

Patient characteristics.

CharacteristicsNo. of patients% of 82 patients
Age group
 <451822.0
 46–655769.5
 >6678.5
Primary cancer
 Ovary7186.6
 Peritoneal911.0
 Fallopian tube22.4
Histological type
 Serous7287.8
 Endometrioid56.1
 Mucinous11.2
 Clear cell44.9
Stage
 IIIb22.4
 IIIc7490.2
 IV67.3
Surgical method
 Stripping5668.3
 Full-thickness resection1214.6
 Both1417.0
Surgical time
PDS6376.8
IDS1315.9
SDS67.3

[i] PDS, primary debulking surgery; IDS, interval debulking surgery and SDS, secondary debulking surgery.

With regard to FIGO clinical staging, 2 patients were in stage IIIb, 74 were in stage IIIc and 6 patients were in stage IV. Diaphragmatic surgery was performed during PDS in 63 patients, interval debulking surgery (IDS) in 13 and secondary debulking surgery (SDS) in 6 patients. The patients in the IDS group received 2–6 courses of paclitaxel/carboplatin combination chemotherapy prior to undergoing surgery.

Out of the 82 patients, stripping and full-thickness resections were performed in 56 and 12 patients, respectively, and the two procedures were performed in 14 patients. Diaphragmatic tumors were removed completely in 71 patients but incompletely in 11 patients (13.4%). Regarding intra-operative incidental events, unexpected open chest surgery occurred in 5 patients (8.9%) in the group that underwent stripping (Table II). On the other hand, post-operative incidental events including pleural effusion were observed in 43 patients (52.4%). Pleural effusion was observed in 25 patients (44.6%) of the group that underwent stripping, 7 (58.3%) of the group that underwent full-thickness resection and 11 patients (78.6%) of the group that underwent both procedures (Table II). No significant differences among the groups were noted.

Table II

Clinical events among treated patients.

Table II

Clinical events among treated patients.

Surgical methodNo. of patientsUnexpected open chest surgeryPleural effusion


No. of patients%No. of patients%
Stripping5658.92544.6
Full-thickness resection12--758.3
Both14--1178.6

In terms of the timing of the operations, unexpected open chest surgery occurred in 1 out of 63 patients (1.6%) in the PDS group, 4 out of 13 patients (30.8%) in the IDS group and 0 out of 6 patients (0.0%) in the SDS group. Incidences were significantly high in the IDS group (Table III).

Table III

Clinical events classified by surgical time.

Table III

Clinical events classified by surgical time.

Clinical eventPDS (n=63)IDS (n=13)SDS (n=6)



No. of patients%No. of patients%No. of patients%
Unexpected open chesta11.6430.800.0
Pleural effusion3352.3861.5233.3

{ label (or @symbol) needed for fn[@id='tfn2-ol-01-05-0861'] } PDS, primary debulking surgery; IDS, interval debulking surgery and SDS, secondary debulking surgery.

a p<0.001.

Of note is that none of the patients with incidental events required chest drainage or experienced problems during the natural course of the observations.

Discussion

Complete cytoreduction is the principle goal in mullerian carcinomas such as ovarian, tubal and peritoneal carcinomas. However, if this poses obstacles, efforts should be made to the greatest extent possible to make the residual disease less than 1 cm in order to improve prognosis (5). It has also been reported that, following the peritoneum and colon, lesions were frequently observed on the diaphragm. This hypothesis was posited by an analysis of tumor localizations in surgical reports of approximately 200 ovarian cancer cases (7). An analysis of bulky diseases in the upper abdominal region, including the diaphragm cranial to the omentum, has shown that there is a correlation between large-volume ascites and disease sites. The same study also revealed that the percentage of cases resulting in suboptimal cytoreductions increased (8). Thus, diaphragmatic disease is a crucial factor in the treatment of advanced ovarian cancer. Complete and optimal debulking rates are thought to increase if diaphragmatic lesions are removed using surgical procedures. Moreover, a better prognosis is likely to be achieved in comparison with cases which do not undergo diaphragmatic surgery (9,10).

However, diaphragmatic metastases are a common obstacle to optimal cytoreduction for patients with ovarian cancer (10). Care with regard to incidental events associated with diaphragmatic surgery must therefore be exercised at all times. The most common incidental events are increased postoperative pleural effusion. It has been reported that incidences increase particularly when open chest occurs (10). With regard to postoperative incidental events, especially pleural effusion and pneumothorax, Devolder et al investigated 69 ovarian cancer patients who underwent diaphragmatic surgery (11). Of the 69 patients, 17 underwent stripping, 22 coagulation and 30 patients underwent both procedures. Postoperative pleural effusion was reported to have been observed in 41 patients, 3 of whom underwent chest drainage, 7 pleural punctures and 1 patient underwent both procedures. In addition, pneumothorax was observed in 4 out of 69 patients, and 1 of these patients required chest drainage. Moreover, Eisenhauer et al reported that ipsilateral pleural effusion was observed in more than half of the patients (an overall rate of 58%) that underwent diaphragmatic peritonectomies or resections. These authors concluded that conservative management is possible in the majority of cases without the need for chest tubes or thorcentesis (12). Postoperative pleural effusion, which may pose clinical obstacles, was not observed in the present study of 82 patients, nor was routine chest tube placement performed at the time of stripping or full-thickness resection. Postoperative pneumothorax was observed at an overall rate of 2.4% (2/82 patients). However, it was possible to prevent pneumothorax from occurring through the use of adequate vacuuming prior to closing the chest (13). Attention should therefore be paid when performing IDS since, as previously analyzed, the incidence of postoperative incidental events was significantly high in the case of diaphragmatic surgery following IDS. Disseminated tumors on the diaphragm, observed prior to neoadjuvant chemotherapy, are thought to induce changes such as necrosis and weakening of the layer structure of the diaphragm.

As observed in attempts at using EndoGIA stapling devices or Gore-tex grafts in diaphragmatic resections or diaphragmatic reconstructions (14), diaphragmatic surgery is likely to be actively performed in the future with respect to advanced ovarian cancer (with peritoneal or fallopian tube cancer). However, the prevention of postoperative complications and incidental events should be further investigated.

References

1 

Hoskins WJ, McGuire WP, Brady MF, et al: The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol. 170:974–980. 1994. View Article : Google Scholar

2 

Bristow RE, Tomacruz RS, Armstrong DK, et al: Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 20:1248–1259. 2002. View Article : Google Scholar : PubMed/NCBI

3 

Chi DS, Franklin CC, Levine DA, et al: Improved optimal cytoreduction rates for stages IIIc and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecol Oncol. 94:650–654. 2004. View Article : Google Scholar : PubMed/NCBI

4 

Eisenhauer EL, Abu-Rustum NR, Sonoda Y, et al: The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIc-IV epithelial ovarian cancer. Gynecol Oncol. 103:1083–1090. 2006. View Article : Google Scholar : PubMed/NCBI

5 

Chi DS, Eisenhauer EL, Lang J, et al: What is the goal of primary cytoreductive surgery for bulky stage IIIc epithelial ovarian carcinoma (EOC)? Gynecol Oncol. 103:559–564. 2006. View Article : Google Scholar : PubMed/NCBI

6 

Kehoe SM, Eisenhauer EL and Chi DS: Upper abdominal surgical procedures; liver mobilization and diaphragm peritonectomy/resection, splenectomy, and distal pancreatectomy. Gynecol Oncol. 111:S51–S55. 2008. View Article : Google Scholar

7 

Sehouli J, Senyuva F, Fotopoulou C, et al: Intra-abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer. J Surg Oncol. 99:424–427. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Zivanovic O, Eisenhauer EL, Zhou Q, et al: The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIc epithelial ovarian, fallopian tube, and primary peritoneal cancer. Gynecol Oncol. 108:287–292. 2008. View Article : Google Scholar

9 

Aletti GD, Dowdy SC, Podratz KC, et al: Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer. Gynecol Oncol. 100:283–287. 2006. View Article : Google Scholar : PubMed/NCBI

10 

Dowdy SC, Loewen RT, Aletti G, et al: Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma. Gynecol Oncol. 109:303–307. 2008. View Article : Google Scholar : PubMed/NCBI

11 

Devolder K, Amant F, Neven P, et al: Role of diaphragmatic surgery in 69 patients with ovarian carcinoma. Int J Gynecol Cancer. 18:363–368. 2008. View Article : Google Scholar : PubMed/NCBI

12 

Eisenhauer EL, D'Angelica MI, Abu-Rustum NR, et al: Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer. Gynecol Oncol. 103:871–877. 2006. View Article : Google Scholar : PubMed/NCBI

13 

Terauchi F, Kobayashi Y, Nagashima T, et al: Pilot study on transdiaphragmatic thoracoscopic-assisted pleural biopsy and intrathoracic washing cytology for stage IIIc ovarian cancer with diaphragmatic metastases. Int J Gynecol Cancer. 19:300–303. 2009. View Article : Google Scholar

14 

Juretzka MM, Horton FR, Abu-Rustum NR, et al: Full-thickness diaphragmatic resection for stage IV ovarian carcinoma using the EndoGIA stapling device followed by diaphragmatic reconstruction using a Gore-tex graft; a case report and review of the literature. Gynecol Oncol. 100:618–620. 2006. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Terauchi F, Okamoto A, Wada Y, Hasegawa E, Sasaki T, Akutagawa O, Sagawa Y, Nishi H and Isaka K: Incidental events of diaphragmatic surgery in 82 patients with advanced ovarian, primary peritoneal and fallopian tubal cancer . Oncol Lett 1: 861-864, 2010.
APA
Terauchi, F., Okamoto, A., Wada, Y., Hasegawa, E., Sasaki, T., Akutagawa, O. ... Isaka, K. (2010). Incidental events of diaphragmatic surgery in 82 patients with advanced ovarian, primary peritoneal and fallopian tubal cancer . Oncology Letters, 1, 861-864. https://doi.org/10.3892/ol_00000152
MLA
Terauchi, F., Okamoto, A., Wada, Y., Hasegawa, E., Sasaki, T., Akutagawa, O., Sagawa, Y., Nishi, H., Isaka, K."Incidental events of diaphragmatic surgery in 82 patients with advanced ovarian, primary peritoneal and fallopian tubal cancer ". Oncology Letters 1.5 (2010): 861-864.
Chicago
Terauchi, F., Okamoto, A., Wada, Y., Hasegawa, E., Sasaki, T., Akutagawa, O., Sagawa, Y., Nishi, H., Isaka, K."Incidental events of diaphragmatic surgery in 82 patients with advanced ovarian, primary peritoneal and fallopian tubal cancer ". Oncology Letters 1, no. 5 (2010): 861-864. https://doi.org/10.3892/ol_00000152
Copy and paste a formatted citation
x
Spandidos Publications style
Terauchi F, Okamoto A, Wada Y, Hasegawa E, Sasaki T, Akutagawa O, Sagawa Y, Nishi H and Isaka K: Incidental events of diaphragmatic surgery in 82 patients with advanced ovarian, primary peritoneal and fallopian tubal cancer . Oncol Lett 1: 861-864, 2010.
APA
Terauchi, F., Okamoto, A., Wada, Y., Hasegawa, E., Sasaki, T., Akutagawa, O. ... Isaka, K. (2010). Incidental events of diaphragmatic surgery in 82 patients with advanced ovarian, primary peritoneal and fallopian tubal cancer . Oncology Letters, 1, 861-864. https://doi.org/10.3892/ol_00000152
MLA
Terauchi, F., Okamoto, A., Wada, Y., Hasegawa, E., Sasaki, T., Akutagawa, O., Sagawa, Y., Nishi, H., Isaka, K."Incidental events of diaphragmatic surgery in 82 patients with advanced ovarian, primary peritoneal and fallopian tubal cancer ". Oncology Letters 1.5 (2010): 861-864.
Chicago
Terauchi, F., Okamoto, A., Wada, Y., Hasegawa, E., Sasaki, T., Akutagawa, O., Sagawa, Y., Nishi, H., Isaka, K."Incidental events of diaphragmatic surgery in 82 patients with advanced ovarian, primary peritoneal and fallopian tubal cancer ". Oncology Letters 1, no. 5 (2010): 861-864. https://doi.org/10.3892/ol_00000152
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team